NCT00816686View on ClinicalTrials.gov

A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Carcinoma, Renal CellKidney NeoplasmsKidney Diseases
Interventions
BIOLOGICAL

AGS-16M18

IV Infusion

Trial Locations (2)

10021

New York

21231

Baltimore

Sponsors

Collaborators (1)

Agensys, Inc.
All Listed Sponsors
collaborator

Agensys, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00816686 - A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer | Biotech Hunter | Biotech Hunter